| Term 
 
        | definition of muscular dystrophy |  | Definition 
 
        | progressive weakness and degeneration of skeletal muscles through destruction of myofibrils; genetically inherited and no cure |  | 
        |  | 
        
        | Term 
 
        | Duchenne Muscular Dystrophy (DMD) pathophysiology |  | Definition 
 
        | ABSENCE of protein dystrophin which provides mechanical stability to sarcolemma (w/o dystrophin sarcolemma is fragile and unable to withstand stress of normal muscle contraction; found in skeletal and cardiac muscle) |  | 
        |  | 
        
        | Term 
 
        | muscular dystrophy etiology |  | Definition 
 
        | x-linked disorder, mainly affects boys, onset 4-5 y/o |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | insidious weakness (by age 4-5 will c/o dec. in ability to run or climb stairs); muscle biopsy positive for c.t. and fatty deposits where muscle tissue should be (absent/abnormal dystrophin gene); blood tests positive for elevated creatine kinase level (indication of cell death) >10x normal; pseudo-hypertrophy calf muscles; positive Gower's sign |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | contractures (esp gastroc/soleus w/ PF contracture), postural mal-alignment ("hang out" on lig./lordosis and winging of scapula), scoliosis, dec. respiratory capacity/endurance, obesity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. 2-5 y/o: signs of clumsiness 2. 4-5 y/o: difficulty running and climbing stairs
 3. 5-7 y/o: PF contractures, lordotic posture, positive Gower's sign
 4. 8-10 y/o: walking limited w/ inc. freq. of falls (start WC use)
 5. 10-14 y/o: loss of ambulation
 6. 20-30's: death secondary to cardiac or respiratory impairment
 |  | 
        |  | 
        
        | Term 
 
        | associated medical conditions |  | Definition 
 
        | scoliosis, cardiomyopathy, pulmonary deficits (in adolescence), cardiac and pulmonary testing must be done annually |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. slow down destruction of muscle 2. prednisone (steroid) to dec. inflamm
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1. prolong child's indep. w/ assistive devices and adaptive equip. (prolong ambulation) 2. educate caregivers as child's fxn changes over time
 3. slow progression of secondary cond.
 4. improve QOL
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inc. susceptibility to injury due to absent dystrophin but moderate resistive exercises may slow muscle weakness w/o neg. effect; avoid exhaustive or maximal effort (aquatic therapy, TB) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | major problem and may contribute to decline in ambulation more than loss of strength; surgical muscle lengthening often needed |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | prolonged assisted standing and walking but req. a greater amt of energy expenditure to walk so not very fxnal |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ABNORMAL quality/quantity of dystrophin; slower progression than DMD and more rare; life expectancy into the 40's or normal; less contractures or scoliosis; not IDed until late childhood or early adolescence; walk through teen years and may req. WC in 20's; vocational training and instruction and training for self-care |  | 
        |  |